FIELD: medicine.
SUBSTANCE: combined preparation containing thioctic acid in amount 100 to 1000 mg and dalargin in amount 0.1 to 4 mg is applied. The method of treating vascular complications of diabetes and diabetic polyneuropathy implies application of intravenous infusion of thioctic acid and dalargin in a pharmaceutically acceptable solvent within 2 courses of 10 days with a two-week interval. The preferential version of the composition is that one containing thioctic acid (300-600 mg), dalargin 3 mg and physiologic saline (250 ml). Application of the invention allows for prompt reduction or complete elimination of morbidity of vascular complications of diabetes and diabetic polyneuropathy.
EFFECT: development of the effective drug combination, improved life quality of the patients, reduced frequency of invalidisation, extended range of drug products for treating complications of pancreatic diabetes.
5 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING VASCULAR DISORDERS AND NEUROPATHIES | 2013 |
|
RU2521199C1 |
METHOD OF TREATING PATIENTS WITH DIABETIC NEUROPATHY | 2017 |
|
RU2690745C1 |
METHOD FOR TREATING DIABETIC ANGIOPATHIES OF LOWER EXTREMITIES | 2017 |
|
RU2644292C1 |
METHOD FOR TREATING DIABETIC POLYNEUROPATHY | 2000 |
|
RU2191011C2 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF DIABETIC POLYNEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DYSLIPIDEMIA | 2011 |
|
RU2491925C2 |
METHOD OF INCREASING BONE MINERAL DENSITY IN PATIENTS WITH OSTEOPOROSIS AND POLYNEUROPATHY IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2799244C1 |
METHOD OF INCREASING BONE MINERAL DENSITY IN PATIENTS WITH OSTEOPOROSIS AND POLYNEUROPATHY IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2804401C1 |
METHOD OF INCREASING BONE MINERAL DENSITY IN PATIENTS WITH OSTEOPOROSIS AND POLYNEUROPATHY IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2804251C1 |
METHOD FOR TREATING DIABETIC POLYNEUROPATHY | 2004 |
|
RU2262928C1 |
METHOD OF INCREASING BONE MINERAL DENSITY IN PATIENTS WITH OSTEOPOROSIS AND POLYNEUROPATHY IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2801087C1 |
Authors
Dates
2010-02-10—Published
2008-07-07—Filed